The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Requirement for the heart‐type fatty acid binding protein in cardiac fatty acid utilization
Abstract
Nonenzymatic cytosolic fatty acid binding proteins (FABPs) are abundantly expressed in many animal tissues with high rates of fatty acid metabolism. No physiological role has been demonstrated for any FABP, although these proteins have been implicated in transport of free long‐chain fatty acids (LCFAs) and protection against LCFA toxicity. We report here that mice lacking heart‐type FABP (H‐FABP) exhibit a severe defect of peripheral (non‐hepatic, non‐fat) LCFA utilization. In these mice, the heart is unable to efficiently take up plasma LCFAs, which are normally its main fuel, and switches to glucose usage. Altered plasma levels of LCFAs, glucose, lactate and β‐hydroxybutyrate are consistent with depressed peripheral LCFA utilization, intensified carbohydrate usage, and increased hepatic LCFA oxidation; these changes are most pronounced under conditions favoring LCFA oxidation. H‐FABP deficiency is only incompletely compensated, however, causing acute exercise intolerance and, at old age, a localized cardiac hypertrophy. These data establish a requirement for H‐FABP in cardiac intracellular lipid transport and fuel selection and a major role in metabolic homeostasis. This new animal model should be particularly useful for investigating the significance of peripheral LCFA utilization for heart function, insulin sensitivity, and blood pressure.—Binas, B., Danneberg, H., McWhir, J., Mullins, L., Clark, A. J. Requirement for the heart‐type fatty acid binding protein in cardiac fatty acid utilization. FASEB J. 13, 805–812 (1999)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular Analysis
McGarry, J. D., & Brown, N. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00001.x · Cited by 1,616
Maniatis, T. (1989) · Medical Entomology and Zoology · Cited by 1,179
Abumrad, N. A., el-Maghrabi, M. R., Amri, E. Z., Lopez, E., & Grimaldi, P. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46753-6 · Cited by 1,002
Hotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 918
Chien, K. R., Knowlton, K. U., Zhu, G., & Chien, S. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.15.1835945 · Cited by 794
Ockner, R. K., Manning, J. A., Poppenhausen, R. B., & Ho, W. K. L. (1972) · Science · doi:10.1126/science.177.4043.56 · Cited by 721
Stanley, W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00245-3 · Cited by 606
Cellular fatty acid-binding proteins: Their function and physiological significance
Glatz, J. F. C., & van der Vusse, G. J. (1996) · Progress in Lipid Research · doi:10.1016/s0163-7827(96)00006-9 · Cited by 566
A Mouse Model of Familial Hypertrophic Cardiomyopathy
Geisterfer-Lowrance, A. A. T., Christe, M., Conner, D. A., Ingwall, J. S., Schoen, F. J., Seidman, C. E., & Seidman, J. G. (1996) · Science · doi:10.1126/science.272.5262.731 · Cited by 556
Mishkin, S., Stein, L., Gatmaitan, Z., & Arias, I. M. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90931-x · Cited by 259
Cited by
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
Furuhashi, M., & Hotamisligil, G. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2589 · Cited by 1,785
Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2010) · Physiological Reviews · doi:10.1152/physrev.00003.2009 · Cited by 751
Coburn, C. T., Knapp, F. F., Febbraio, M., Beets, A. L., Silverstein, R. L., & Abumrad, N. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003826200 · Cited by 726
Bensaad, K., Favaro, E., Lewis, C. A., Peck, B., Lord, S., Collins, J. M., Pinnick, K. E., Wigfield, S., Buffa, F. M., Li, J.-L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.056 · Cited by 665
New insights into the structure and function of fatty acid-binding proteins
Zimmerman, A. W., & Veerkamp, J. H. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8490-y · Cited by 547
The fatty acid transport function of fatty acid-binding proteins
Storch, J., & Thumser, A. E. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00046-9 · Cited by 528
PPAR Signaling in the Control of Cardiac Energy Metabolism
Barger, P. M., & Kelly, D. P. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00077-3 · Cited by 506
Skeletal Muscle Lipid Metabolism in Exercise and Insulin Resistance
Kiens, B. (2006) · Physiological Reviews · doi:10.1152/physrev.00023.2004 · Cited by 478
The Emerging Functions and Mechanisms of Mammalian Fatty Acid–Binding Proteins
Storch, J., & Corsico, B. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093710 · Cited by 470
Fatty acid-binding proteins – insights from genetic manipulations
Haunerland, N. H., & Spener, F. (2004) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.05.001 · Cited by 444
Control of mitochondrial β-oxidation flux
Eaton, S. (2002) · Progress in Lipid Research · doi:10.1016/s0163-7827(01)00024-8 · Cited by 411
Vogel Hertzel, A., & Bernlohr, D. A. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00257-5 · Cited by 404
Tissue-specific Functions in the Fatty Acid-binding Protein Family
Storch, J., & Thumser, A. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.135210 · Cited by 363
Cardiac fatty acid uptake and transport in health and disease
van der Vusse, G. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00263-1 · Cited by 318
Planavila, A., Iglesias, R., Giralt, M., & Villarroya, F. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq376 · Cited by 317
Fatty Acid Binding Proteins—The Evolutionary Crossroads of Inflammatory and Metabolic Responses
Makowski, L., & Hotamisligil, G. S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.9.2464s · Cited by 311
Corpeleijn, E., Saris, W. H. M., & Blaak, E. E. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00544.x · Cited by 280
“Studies with FABPc knockout mice indicated the involvement of FABPc in shuttling LCFAs from the sarcolemma to intracellular sites of oxidation or esterification, but rather in a permissive than in a regulatory way (42,43).”
BackgroundMarszalek, J. R., & Lodish, H. F. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120624 · Cited by 270
Cytoplasmic fatty acid‐binding protein facilitates fatty acid utilization by skeletal muscle
Glatz, J. F. C., Schaap, F. G., Binas, B., Bonen, A., Van Der Vusse, G. J., & Luiken, J. J. F. P. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01166.x · Cited by 259
Self-citationCharacterization of a Heart-specific Fatty Acid Transport Protein
Gimeno, R. E., Ortegon, A. M., Patel, S., Punreddy, S., Ge, P., Sun, Y., Lodish, H. F., & Stahl, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211412200 · Cited by 218
Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia
Kaczocha, M., Rebecchi, M. J., Ralph, B. P., Teng, Y.-H. G., Berger, W. T., Galbavy, W., Elmes, M. W., Glaser, S. T., Wang, L., Rizzo, R. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094200 · Cited by 142
“As an additional objective, the inhibitors were designed to exhibit limited binding to FABP3 because ablation of this protein has been previously shown to contribute to age-related cardiac hypertrophy [39].”
BackgroundGuidelines for animal exercise and training protocols for cardiovascular studies
Poole, D. C., Copp, S. W., Colburn, T. D., Craig, J. C., Allen, D. L., Sturek, M., O’Leary, D. S., Zucker, I. H., & Musch, T. I. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00697.2019 · Cited by 139
Fatty Acid Binding Protein: Localization and Functional Significance in the Brain
Owada, Y. (2008) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.214.213 · Cited by 122
Kawahata, I., Bousset, L., Melki, R., & Fukunaga, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215358 · Cited by 56
“FABP3−/− mice [39,40] were housed under climate-controlled conditions with a 12-h light and dark cycle.”
MethodJiang, X., Lian, X., Wei, K., Zhang, J., Yu, K., Li, H., Ma, H., Cai, Y., & Pang, L. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03961-4 · Cited by 23
Metadata
- Authors
- Binas, B., Danneberg, H., Mcwhir, J., Mullins, L., & Clark, A. J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1999-05
- Volume
- 13
- Issue
- 8
- Pages
- 805-812
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2154584898
- Cited by
- 314
- References
- 28
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.